Clinical Research Center

The CRC is fully staffed with full time investigators and credentialed, experienced and qualified research raters and staff. The CRC is a highly sought after site and have a national reputation for successful completion and recruitment including rapid site start up.  

The CRC has successfully completed over 100 phase 0, I, II, III and IV clinical trials and actively involved in investigations of:

• Alzheimer’s, MCI, Preclinical and other related neurodegenerative disorders
• Parkinson’s, & other movement disorders including Huntington’s chorea, tremors
• Epilepsy, Seizures including acute abortive therapies in overnight EMU
• MS, Neuroimmunology, Vaccine research
• Pain, Headache, Migraines research
• Neuromuscular including myasthenia gravis research
• Concussion, traumatic brain injury
• Narcolepsy, Insomnia and other sleep disorders
• Stroke and Neurovascular research
• Neurodevice, neuromodulation studies
• Rare Neurological Diseases
• IV Infusion studies in IV Infusion Center
• Biomarker (CSF, serum, genetic) sampling, PK study in overnight PK unit
• Phase 0 & Phase I Normal volunteer & PK studies in overnight PK Unit

Few examples of successfully investigated, FDA approved and launched products include Cenobamate for Epilepsy, Inbrija for Parkinson’s, Kesimpta for MS, Daridorexant for Insomnia in recent years.